ImmunoAIzer: A Deep Learning-Based Computational Framework to Characterize Cell Distribution and Gene Mutation in Tumor Microenvironment
Autor: | Yu Wang, Zhihao Lu, Chang Bian, Yang Du, Lingxin Kong, Yu An, Jie Tian, Hanfan Wang |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
semi-supervised learning Cancer Research hematoxylin and eosin (H&E) Colorectal cancer medicine.medical_treatment E) Gene mutation Biology lcsh:RC254-282 Article tumor gene mutation 03 medical and health sciences 0302 clinical medicine Cancer immunotherapy medicine tumor microenvironment (TME) Tumor microenvironment Tumor-infiltrating lymphocytes deep learning Immunotherapy medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens cell distribution 030104 developmental biology Oncology 030220 oncology & carcinogenesis Cancer cell Cancer research Biomarker (medicine) biomarker hematoxylin and eosin (H& |
Zdroj: | Cancers Volume 13 Issue 7 Cancers, Vol 13, Iss 1659, p 1659 (2021) |
ISSN: | 2072-6694 |
Popis: | Spatial distribution of tumor infiltrating lymphocytes (TILs) and cancer cells in the tumor microenvironment (TME) along with tumor gene mutation status are of vital importance to the guidance of cancer immunotherapy and prognoses. In this work, we developed a deep learning-based computational framework, termed ImmunoAIzer, which involves: (1) the implementation of a semi-supervised strategy to train a cellular biomarker distribution prediction network (CBDPN) to make predictions of spatial distributions of CD3, CD20, PanCK, and DAPI biomarkers in the tumor microenvironment with an accuracy of 90.4% (2) using CBDPN to select tumor areas on hematoxylin and eosin (H& E) staining tissue slides and training a multilabel tumor gene mutation detection network (TGMDN), which can detect APC, KRAS, and TP53 mutations with area-under-the-curve (AUC) values of 0.76, 0.77, and 0.79. These findings suggest that ImmunoAIzer could provide comprehensive information of cell distribution and tumor gene mutation status of colon cancer patients efficiently and less costly hence, it could serve as an effective auxiliary tool for the guidance of immunotherapy and prognoses. The method is also generalizable and has the potential to be extended for application to other types of cancers other than colon cancer. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |